A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile
Open Access
- 1 July 2013
- journal article
- Published by Microbiology Society in Microbiology
- Vol. 159 (Pt_7), 1254-1266
- https://doi.org/10.1099/mic.0.066712-0
Abstract
The Clostridium difficile toxins A and B are primarily responsible for symptoms of C. difficile associated disease and are prime targets for vaccine development. We describe a plasmid-based system for the production of genetically modified toxins in a non-sporulating strain of C. difficile that lacks the toxin genes tcdA and tcdB. TcdA and TcdB mutations targeting established glucosyltransferase cytotoxicity determinants were introduced into recombinant plasmids and episomally expressed toxin mutants purified from C. difficile transformants. TcdA and TcdB mutants lacking glucosyltransferase and autoproteolytic processing activities were ~10 000-fold less toxic to cultured human IMR-90 cells than corresponding recombinant or native toxins. However, both mutants retained residual cytotoxicity that could be prevented by preincubating the antigens with specific antibodies or by formalin treatment. Such non-toxic formalin-treated mutant antigens were immunogenic and protective in a hamster model of infection. The remaining toxicity of untreated TcdA and TcdB mutant antigens was associated with cellular swelling, a phenotype consistent with pore-induced membrane leakage. TcdB substitution mutations previously shown to block vesicular pore formation and toxin translocation substantially reduced residual toxicity. We discuss the implications of these results for the development of a C. difficile toxoid vaccine.Keywords
This publication has 39 references indexed in Scilit:
- Clostridium difficile Toxin B Causes Epithelial Cell Necrosis through an Autoprocessing-Independent MechanismPLoS Pathogens, 2012
- Global transcriptional control by glucose and carbon regulator CcpA in Clostridium difficileNucleic Acids Research, 2012
- Secretion of Clostridium difficile Toxins A and B Requires the Holin-like Protein TcdEPLoS Pathogens, 2012
- Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin BMolecular Microbiology, 2011
- Characterization of the Sporulation Initiation Pathway of Clostridium difficile and Its Role in Toxin ProductionJournal of Bacteriology, 2009
- Production of Clostridium difficile toxin in a medium totally free of both animal and dairy proteins or digestsProceedings of the National Academy of Sciences of the United States of America, 2009
- A modular system for Clostridium shuttle plasmidsJournal of Microbiological Methods, 2009
- The ClosTron: A universal gene knock-out system for the genus ClostridiumJournal of Microbiological Methods, 2007
- Application of Mutated Clostridium difficile Toxin A for Determination of Glucosyltransferase-Dependent EffectsInfection and Immunity, 2006
- The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genomeNature Genetics, 2006